Author

Aekagra Singh

Institution: All India Institute of Medical Sciences

Observed institutions: Shiv Nadar University, All India Institute of Medical Sciences

ORCID: 0000-0003-4274-0755

Observed ORCID: 0000-0003-4274-0755

OpenAlex ID: A5073156483

Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies

2022 · Rajkumar Kulandaisamy, Tushar Kushwaha, et al. · Frontiers in Microbiology · 21

Identification of a novel inhibitor of SARS‐CoV ‐2 main protease: an in silico , biochemical, and cell‐based approach

2023 · Aditya Trivedi, Vandana Kardam, et al. · FEBS Journal · 7

Cryo-EM structures of Mycobacterium tuberculosis pyruvate carboxylase reveal acetyl-CoA-mediated tetramer stabilization and carrier-domain coordination

2026 · Aekagra Singh, Sandeep Singh, et al. · Communications Biology

Biophysical Characterization of Phosphatidylinositol 3-Kinase-γ as a Drug Target: Implications for the Development of Potent Inhibitory Drug Molecules for Alzheimer’s Disease (P6-12.014)

2026 · GURURAO HARIPRASAD, Sagar Rathee, et al. · Neurology

Cryo-EM structures of Mycobacterium tuberculosis pyruvate carboxylase reveal allosteric activation and domain dynamics during catalysis

2025 · Aekagra Singh, Sandeep Singh, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Author response for "Identification of a novel inhibitor of SARS‐CoV ‐2 main protease: an in silico, biochemical, and cell‐based approach"

2023 · Aditya Trivedi, Vandana Kardam, et al.

Works count: 7

Citation count: 28

H-index: 2

I10-index: 1